New ALS Segment on Lifetime’s Behind the Mystery Airing 5/4/2017

April 27, 2017

Lifetime’s Behind the Mystery will be featuring a new segment on May 4th, 2017 about ALS.


ALS is a rare, debilitating neurodegenerative disease that can affect anyone.  We’ll meet a man who has been diagnosed with ALS and faces daily challenges associated with the disease. We’ll also hear from Dr. Steven Perrin, CEO and Chief Scientific Officer at the ALS Therapy Development Institute in Cambridge, MA, who will explain the latest research in their dedicated efforts to seek a cure.  It’s part of the Mystery Behind the Rare Disease series on the Balancing Act.

Stay Connected

Sign up for updates straight to your inbox.